We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$39.9B
AUM Growth
+$3.72B
Cap. Flow
+$509M
Cap. Flow %
1.27%
Top 10 Hldgs %
16.29%
Holding
1,663
New
124
Increased
511
Reduced
452
Closed
47

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$75.9M
2
AAPL icon
Apple
AAPL
+$62.8M
3
CELG
Celgene Corp
CELG
+$62.4M
4
MRK icon
Merck
MRK
+$56.8M
5
MSFT icon
Microsoft
MSFT
+$44.4M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Financials 16.85%
3 Healthcare 13.06%
4 Industrials 9.99%
5 Consumer Discretionary 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTS
1526
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$335K ﹤0.01%
37,400
PINC
1527
DELISTED
Premier
PINC
$332K ﹤0.01%
8,769
+1,430
+19% +$50.3K
HTT
1528
High Templar Tech Ltd
HTT
$391M
$331K ﹤0.01%
70,249
-30,908
-31% -$182K
TREE icon
1529
LendingTree
TREE
$446M
$331K ﹤0.01%
1,091
SFM icon
1530
Sprouts Farmers Market
SFM
$7.78B
$325K ﹤0.01%
16,772
MD icon
1531
Pediatrix Medical
MD
$2.12B
$324K ﹤0.01%
11,673
NUS icon
1532
Nu Skin
NUS
$235M
$319K ﹤0.01%
7,773
TRN icon
1533
Trinity Industries
TRN
$2.32B
$318K ﹤0.01%
14,340
-510
-3% -$10.4K
KALV
1534
DELISTED
KalVista Pharmaceuticals
KALV
$312K ﹤0.01%
17,500
UFS
1535
DELISTED
DOMTAR CORPORATION (New)
UFS
$311K ﹤0.01%
8,134
-750
-8% -$27.8K
HAIN icon
1536
Hain Celestial
HAIN
$53.8M
$308K ﹤0.01%
11,848
-1,040
-8% -$24.9K
VRCA icon
1537
Verrica Pharmaceuticals
VRCA
$84.2M
$308K ﹤0.01%
1,940
ECHO
1538
EchoStar
ECHO
$26.6B
$304K ﹤0.01%
7,023
+310
+5% +$12.4K
SYRE icon
1539
Spyre Therapeutics
SYRE
$9.06B
$303K ﹤0.01%
1,588
+805
+103% +$158K
NERV icon
1540
Minerva Neurosciences
NERV
$189M
$301K ﹤0.01%
5,288
SITC icon
1541
SITE Centers
SITC
$158M
$300K ﹤0.01%
27,442
+1,897
+7% +$21.6K
WLY icon
1542
John Wiley & Sons Class A
WLY
$2.6B
$300K ﹤0.01%
6,179
ESRT icon
1543
Empire State Realty Trust
ESRT
$836M
$299K ﹤0.01%
21,432
+540
+3% +$7.58K
CNCE
1544
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$298K ﹤0.01%
32,300
AKCA
1545
DELISTED
Akcea Therapeutics Inc
AKCA
$298K ﹤0.01%
17,600
CBMG
1546
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$294K ﹤0.01%
18,200
SBGI icon
1547
Sinclair Inc
SBGI
$1.01B
$289K ﹤0.01%
8,674
UBX
1548
DELISTED
Unity Biotechnology
UBX
$289K ﹤0.01%
4,010
PTEN icon
1549
Patterson-UTI
PTEN
$4.19B
$286K ﹤0.01%
27,252
-1,350
-5% -$12.2K
SRRK icon
1550
Scholar Rock
SRRK
$6.68B
$285K ﹤0.01%
21,600

Similar funds

State of Wisconsin Investment Board's Q4 2019 Portfolio in Review

As of Q4 2019, State of Wisconsin Investment Board held 1,663 positions worth $39.9B, up 10% from $36.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q4 2019 filing shows 124 new, 511 increased, 452 reduced and 47 closed positions. Its largest new stake was CDW: 135,554 shares worth $19.4M. The largest sale was Intel, an estimated $75.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q4 2019 buy was CDW: 135,554 shares worth $19.4M.
  • State of Wisconsin Investment Board added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $71.1M increase.
  • State of Wisconsin Investment Board's biggest Q4 2019 reduction was Intel, cutting an estimated $75.9M.
  • State of Wisconsin Investment Board fully exited Celgene Corp in Q4 2019, selling an estimated $62.4M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $39.9B portfolio in Q4 2019.
  • State of Wisconsin Investment Board opened 124 new positions and closed 47 in Q4 2019.
  • State of Wisconsin Investment Board's portfolio value rose 10% quarter-over-quarter to $39.9B.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2019, filed 14 Feb 2020.